Ozempic treatment for weight loss
Ozempic Treatment for Weight Loss in Bhopal
The conversation around medical weight loss shifted the moment semaglutide hit the headlines, a diabetes drug that doubled as a weight-loss powerhouse. The clinical evidence backing it up is hard to ignore. If you’ve cycled through diet plans, gym routines, and every trending wellness hack without lasting results, an Ozempic treatment for weight loss might be the medical intervention your body has been waiting for.
At Nikky Bawa Medi Salon, Dr. Sahiba Bawa runs medically supervised weight loss protocols from our Bhopal clinic. Every patient receives a structured programme built around their metabolic profile, body composition, and health history; not a generic off-the-shelf plan.
We operate from Ajay Tower, E 5/1, Bittan Market, Bhopal, Madhya Pradesh 462016.
What Is Ozempic and How Does It Actually Work?
How does Ozempic work in the body?
The active ingredient, semaglutide, mimics a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), the hormone responsible for appetite regulation and blood sugar management. When semaglutide binds to GLP-1 receptors in the brain, it amplifies the satiety signals your body normally sends after a meal.
The result? A cascade of metabolic changes that actively work in your favour:
- GLP-1 receptor activation in the hypothalamus reduces hunger signalling, leading to earlier satiety and smaller meal portions — without conscious restriction
- Gastric emptying slows by approximately 20–30%, extending the feeling of fullness after meals and reducing the urge to snack.
- Insulin secretion improves, reducing post-meal glucose spikes and improving overall metabolic flexibility
- Glucagon release from the pancreas is suppressed, preventing unnecessary glucose production by the liver and supporting stable blood sugar
- Reward pathways in the brain show reduced activation in response to high-fat and high-sugar foods, naturally decreasing cravings
Important distinction: This is not about artificially suppressing your appetite. It’s about restoring the hormonal signalling that tells your body when it has genuinely had enough to eat. For many patients with obesity, these signals have been dysfunctional for years.
Origin Story: Semaglutide was originally developed to manage Type 2 diabetes by Novo Nordisk, designed with a longer half-life than its predecessor liraglutide, enabling once-weekly rather than daily dosing. This pharmacokinetic advantage proved critical for patient compliance. The dramatic weight loss observed during diabetes trials triggered dedicated weight management studies, and the results redefined what pharmacological weight loss could achieve.
The Clinical Evidence: What the Data Actually Shows
The STEP (Semaglutide Treatment Effect in People with Obesity) trial programme is the largest body of evidence for semaglutide in weight management. Across five major trials involving over 5,000 participants, the data tells a consistent story.
- STEP 1 (1,961 adults, BMI 30+): Average weight loss of 14.9% vs 2.4% for placebo over 68 weeks. Nearly 70% of participants lost at least 10% of body weight. (Wilding et al., New England Journal of Medicine, 2023)
- STEP 5 (2-year follow-up): Long-term treatment with semaglutide maintained clinically meaningful weight loss over 2 years. (Wilding et al., Nature Medicine, 2022)
- SELECT cardiovascular outcomes trial (2023): Semaglutide reduced the risk of major adverse cardiovascular events by 20% in overweight or obese adults without diabetes — the first time a weight loss medication demonstrated a direct cardiovascular benefit. (Lincoff et al., New England Journal of Medicine, 2023)
- Real-world evidence (2024): Real-world evidence (2024-2025): Real-world studies report 10-18% weight loss at 12 months with semaglutide, approaching STEP trial results. (Obes Surg 2025; PubMed; PMC)
Patient Review
Ozempic vs Other Weight Loss Methods: What Actually Works?
Most people searching for an Ozempic injection have already tried conventional approaches. The cycle of losing and regaining weight is exhausting.
Here’s how semaglutide stacks up:
| Treatment | Best For | Sessions Needed | Downtime | Expected Improvement |
|---|---|---|---|---|
| Ozempic (Semaglutide) | BMI 30+ or 27+ with comorbidities | 6–12 months | ₹45K–75K / 6mo | 15–20% body weight |
| Mounjaro (Tirzepatide) | Maximum efficacy seekers | 6–12 months | ₹60K–1L / 6mo | Up to 22.5% |
| Diet and Exercise | First-line for all patients | Lifelong | Minimal | 5–10% body weight |
| Lipotropic Injections | Metabolic boost without systemic meds | 3–6 months | ₹3K–8K / month | 2–4 kg/month |
| Bariatric Surgery | Severe obesity (BMI 40+) | Permanent | ₹2L–5L | 25–35% body weight |
| Orlistat (Oral) | Mild weight loss, oral option | Ongoing | ₹1K–3K / month | 3–5% body weight |
Semaglutide fills a critical gap by delivering results between lifestyle modification and surgical intervention, without the invasiveness or permanence of an operation.
Review
Who Is a Good Candidate for Ozempic?
Are you the right fit for semaglutide?
Not every person who wants to lose weight qualifies for semaglutide. We take candidacy seriously because inappropriate use leads to complications and wasted investment.
You may be a suitable candidate if:
- Your BMI is 30 or above (classified as obese by WHO standards)
- Your BMI is 27 or above with at least one weight-related condition such as hypertension, Type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea
- You have tried structured diet and exercise programmes without achieving sustained weight loss
Contraindications include:
- Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
- Active pancreatitis or severe gastrointestinal disease
- Pregnancy or planned pregnancy within six months
Psychological readiness also matters. Patients who understand that semaglutide is a clinical tool, not a magic solution, consistently achieve better long-term outcomes. Dr. Bawa spends time during the initial consultation setting realistic expectations and building the partnership between medication, nutrition, and movement that produces the best results.
Pre-treatment evaluation includes comprehensive bloodwork (fasting glucose, HbA1c, lipid panel, thyroid function, kidney and liver markers), body composition analysis, and a detailed medical history review. If the data doesn’t support semaglutide therapy, she will recommend a better-fit alternative.
What Is the Ozempic Injection Price in India?
The Ozempic injection price in India depends on dosage strength, branded vs generic semaglutide, and the total duration of treatment. Generic semaglutide formulations entering the Indian market are expected to reduce costs by 30–40% over the next year.
| Dosage | Monthly Cost (INR) | Phase | Duration |
|---|---|---|---|
| 0.25 mg (starter) | ₹4,000 – 6,000 | Initial adaptation | Weeks 1–4 |
| 0.5 mg (step-up) | ₹6,000 – 9,000 | Early treatment | Weeks 5–12 |
| 1.0 mg (therapeutic) | ₹9,000 – 14,000 | Active weight loss | Weeks 13–24 |
| 2.0 mg (maximum) | ₹14,000 – 20,000 | Maximum efficacy | Week 25+ if needed |
| Full 6-month programme | ₹45,000 – 75,000 | Complete protocol | 6 months |
All pricing is discussed transparently before initiating treatment. The total investment includes medication, consultations, bloodwork, and body composition assessments. No hidden charges mid-programme.
What Happens During the Treatment Process?
Your 5-step Ozempic protocol at Nikky Bawa Medi Salon
1. Comprehensive Assessment. Bloodwork covering fasting glucose, HbA1c, lipid panel, thyroid function, liver enzymes, and kidney markers. Body composition analysis measures fat percentage, lean mass, and visceral fat. A detailed medical history covers current medications, allergies, family history, and prior weight loss attempts.
2. Dose Initiation. Treatment begins at 0.25 mg as a once-weekly subcutaneous injection. The low starting dose allows your gastrointestinal system to adapt and minimises the severity of nausea — the most common early side effect.
3. Weekly Check-ins. During the first month, we monitor side effects, appetite changes, weight trajectory, and blood sugar patterns. Any concerning symptoms trigger an immediate clinical review.
4. Dose Escalation. If the starting dose is well-tolerated, we step up to 0.5 mg at week five. Further increases to 1.0 mg or 2.0 mg occur at four-week intervals based on individual response and tolerability. Not everyone needs the maximum dose.
5. Ongoing Programme Management. Monthly body composition assessments track fat loss vs lean mass preservation. Dietary guidance is recalibrated as your metabolism adjusts. Bloodwork at 8–12 week intervals monitors metabolic markers, thyroid function, and pancreatic health.
Long-term maintenance: After the initial 6-month programme, quarterly consultations and annual bloodwork keep your metabolic health on track. Patients who reach their target weight may transition to a lower maintenance dose or discontinue with lifestyle modifications in place — always an individualised, data-driven decision.
Ozempic Alternatives: What If Semaglutide Is Not Right for You?
Semaglutide isn’t appropriate for everyone. Contraindications, cost concerns, or personal preference may lead you toward Ozempic alternatives that work through different mechanisms:
Lipotropic injections: A blend of methionine, inositol, choline, and B-vitamins that support liver function and fat metabolism. Less appetite suppression than semaglutide but ideal for patients who need a metabolic boost without systemic medication.
B12 and MIC injections: Cyanocobalamin combined with lipotropic amino acids to enhance energy production and fat breakdown. Effective as an adjunct to diet and exercise programmes.
HCG protocol: Human chorionic gonadotropin paired with a calorie-restricted diet. Produces rapid initial weight loss, but requires strict adherence and careful medical monitoring due to the very low-calorie intake involved.
EMS body sculpting: High-intensity electromagnetic stimulation that forces supramaximal muscle contractions — building lean muscle while reducing localised fat. No medication involved.
Clinical nutrition programmes: Structured, medically supervised meal plans designed around your metabolic rate, food preferences, and nutritional needs. No fad diets. No elimination protocols.
Combination approaches often yield the best outcomes. A patient on semaglutide who also incorporates lipotropic injections, a structured nutritional plan, and resistance training will typically achieve better body composition results than relying on medication alone. Dr. Bawa designs integrated protocols that layer multiple interventions synergistically.
Side Effects: What You Should Know Before Starting
Common side effects (>10% of patients)
- Nausea (particularly during dose escalation) — affects roughly 40% of patients in the first month
- Diarrhoea or constipation — occurs in about 20% of patients
- Headaches and fatigue during the initial adjustment period — reported by 15–20% of patients
Less common effects (1–10% of patients)
- Vomiting, abdominal pain, injection site reactions (mild redness or itching), occasional dizziness
Serious adverse events (rare)
- Pancreatitis — observed in less than 0.3% of trial participants
- Gallbladder disease — primarily gallstone formation related to rapid weight loss, in approximately 2–3% of patients
- Thyroid C-cell tumours — observed in rodent studies at doses far exceeding human equivalents; not confirmed in human trials
The critical point is supervision. A clinic that dispenses an injection and sends you home without monitoring is not providing adequate care. At Nikky Bawa Medi Salon, we track, adjust, and intervene immediately if warning signs appear.
Emerging research also suggests potential benefits for polycystic ovary syndrome (PCOS), a condition closely linked to insulin resistance and obesity. Emerging 2025 pilot studies show semaglutide improves menstrual regularity and ovarian morphology in PCOS (Clin Nutr ESPEN; PubMed 41421448)
Can Ozempic Help Beyond Weight Loss?
The metabolic benefits of semaglutide extend well beyond what the scale shows. Data from 2023–2025 trials reveal meaningful improvements across multiple health markers:
Cardiovascular protection: The SELECT trial (Lincoff et al., NEJM2023) demonstrated a 20% reduction in heart attacks, strokes, and cardiovascular death
Blood sugar normalisation: In pre-diabetic patients, 84% returned to normal glucose levels during a 68-week treatment period (STEP trials pooled analysis – Perreault et al., Diabetes Care2023))
Liver health: Non-alcoholic fatty liver disease markers improved in over 70% of participants, with measurable reductions in liver fat content (NAFLD/NASH meta-analysis (Newsome et al., J Clin Transl Hepatol2023)
Sleep apnoea: Weight loss from semaglutide reduced obstructive sleep apnoea severity by an average of 30% in a controlled study ((Med Res Arch2025))
Joint health: Reduced mechanical load on weight-bearing joints led to decreased osteoarthritis pain scores in obese patients. Semaglutide reduced knee osteoarthritis
pain by 52% (WOMAC score: -41.7 vs. -27.5 placebo) in obese patients over 68 weeks. (Bliddal et al., NEJM2024; STEP 9 trial)
“For Indian patients with obesity-related metabolic syndrome, GLP-1 receptor agonists offer a targeted approach that addresses the root cause rather than just managing symptoms. The data from recent trials is compelling.” — Dr. Anoop Misra, Chairman, Fortis C-DOC Centre for Diabetes & Metabolic Diseases (Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024)
Short Answer: How Does Ozempic Help with Weight Loss?
Why Choose Nikky Bawa Medi Salon for Your Weight Loss Programme?
- Medical expertise: Dr. Sahiba Bawa holds advanced training from Seoul, South Korea in body contouring and injectable therapies. Weight management is a core clinical focus at our practice.
- Integrated approach: Ozempic injections work best when combined with nutritional guidance, activity planning, and body composition monitoring. We provide the complete stack.
- Honest assessment: If semaglutide is not right for you, we will say so upfront. We do not push medications to meet revenue targets.
- Ongoing support: Weight management is a long-term commitment. Our programme includes monthly follow-ups, periodic bloodwork, and dose adjustments as your body changes.
- FDA-approved medications only: No grey-market imports. No compounded formulations from unknown suppliers. Every injection meets pharmaceutical-grade standards.
Take the First Step
If weight loss has felt inconsistent or frustrating, it may be time to approach it medically. Come speak with us. No pressure. No sales pitch. Just a clear, doctor-led evaluation of what your body actually needs. Contact us today to begin your journey.
Your weight does not define you. But having control over your health does. We are here to guide you with the right tools and the right plan.
Book your consultation at Nikky Bawa Medi Salon, Bittan Market, Bhopal. Dr. Sahiba Bawa will assess your metabolic profile, understand your challenges, and create a structured Ozempic treatment plan tailored to your lifestyle. Contact us to schedule your visit.
Frequently Asked Questions
Both contain semaglutide, but are approved for different indications. Ozempic carries approval for Type 2 diabetes management, while Wegovy is approved specifically for chronic weight management at higher doses (up to 2.4 mg weekly). In India, Ozempic is more widely available and is prescribed off-label for weight loss based on extensive clinical evidence.
Most patients notice a reduction in appetite within the first 7–14 days. Measurable weight loss typically begins by week three or four. Meaningful results (5–10% body weight reduction) usually occur between months three and six, depending on starting weight, dietary adherence, activity levels, and individual metabolic response.
Yes. While Ozempic carries approval for Type 2 diabetes, clinicians prescribe it off-label for weight management in patients meeting BMI criteria (30+, or 27+ with comorbidities). The clinical evidence supporting this use is extensive across the STEP trial programme.
Appetite typically returns to pre-treatment levels within 4–8 weeks of discontinuation. Weight regain is common if lifestyle modifications are not maintained. We implement a gradual tapering protocol and pair it with ongoing nutritional counselling to minimise rebound weight gain.
Current safety data supports continuous use for up to two years, with the STEP 5 trial demonstrating maintained efficacy and safety over 104 weeks. Regular monitoring of metabolic markers, thyroid function, and pancreatic enzymes is part of our standard protocol.
Absolutely. Semaglutide-based weight management is equally effective in men and women. In clinical trials, male participants often achieved slightly faster initial weight loss, likely attributable to higher baseline metabolic rates and greater lean muscle mass.
Any significant weight loss carries the risk of some lean mass reduction. The STEP 1 body composition sub-study showed approximately 40% of weight lost was lean mass. We mitigate this through protein-rich dietary planning (1.2–1.6 g per kg of ideal body weight daily), resistance exercise recommendations, and EMS body sculpting sessions where appropriate.
Schedule a Consultation
Ph: +91 9893544778
Address: Nikky Bawa Medi Salon
BITTAN MARKET, 1st Floor Ajay TowerE-5/1, Arera Colony
Bhopal Madhya Pradesh 462003